Time to reconsider the role of ribavirin in Lassa fever.
Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation o...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4763774884534bc790cd73d9a203fb9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4763774884534bc790cd73d9a203fb9a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4763774884534bc790cd73d9a203fb9a2021-11-25T06:33:32ZTime to reconsider the role of ribavirin in Lassa fever.1935-27271935-273510.1371/journal.pntd.0009522https://doaj.org/article/4763774884534bc790cd73d9a203fb9a2021-07-01T00:00:00Zhttps://doi.org/10.1371/journal.pntd.0009522https://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation of ribavirin is therefore needed.Alex Paddy SalamVincent ChengTansy EdwardsPiero OlliaroJonathan SternePeter HorbyPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 7, p e0009522 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Alex Paddy Salam Vincent Cheng Tansy Edwards Piero Olliaro Jonathan Sterne Peter Horby Time to reconsider the role of ribavirin in Lassa fever. |
description |
Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation of ribavirin is therefore needed. |
format |
article |
author |
Alex Paddy Salam Vincent Cheng Tansy Edwards Piero Olliaro Jonathan Sterne Peter Horby |
author_facet |
Alex Paddy Salam Vincent Cheng Tansy Edwards Piero Olliaro Jonathan Sterne Peter Horby |
author_sort |
Alex Paddy Salam |
title |
Time to reconsider the role of ribavirin in Lassa fever. |
title_short |
Time to reconsider the role of ribavirin in Lassa fever. |
title_full |
Time to reconsider the role of ribavirin in Lassa fever. |
title_fullStr |
Time to reconsider the role of ribavirin in Lassa fever. |
title_full_unstemmed |
Time to reconsider the role of ribavirin in Lassa fever. |
title_sort |
time to reconsider the role of ribavirin in lassa fever. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/4763774884534bc790cd73d9a203fb9a |
work_keys_str_mv |
AT alexpaddysalam timetoreconsidertheroleofribavirininlassafever AT vincentcheng timetoreconsidertheroleofribavirininlassafever AT tansyedwards timetoreconsidertheroleofribavirininlassafever AT pieroolliaro timetoreconsidertheroleofribavirininlassafever AT jonathansterne timetoreconsidertheroleofribavirininlassafever AT peterhorby timetoreconsidertheroleofribavirininlassafever |
_version_ |
1718413615026929664 |